Ellevest Inc’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Ellevest Inc’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19	Closed	–	–	1558
2021 Q2	$0	Hold	19	–	–	﹤0.01%	1401
2021 Q1	$0	Hold	19	–	–	﹤0.01%	1344
2020 Q4	$0	Buy	19 +4	+27%	+$47	﹤0.01%	1338
2020 Q3	$0	Buy	+15	New	+$162	﹤0.01%	1304

Other funds holding SGMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ellevest Inc's SGMO Position: Q3 2021 in Review

Ellevest Inc sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2021, closing a stake of 19 shares.

Ellevest Inc first reported a position in SGMO in Q3 2020 and held it in 4 quarters. The position peaked at $0 in Q2 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q3 2021.

Ellevest Inc reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2021 after selling out during the quarter.
Ellevest Inc sold 19 SANGAMO THERAPEUTICS INC shares in Q3 2021.
Ellevest Inc first reported a position in SANGAMO THERAPEUTICS INC in Q3 2020 and held it in 4 quarters.
Ellevest Inc's SANGAMO THERAPEUTICS INC position peaked at $0 in Q2 2021.
193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2021.

Based on Ellevest Inc's 13F filing for Q3 2021, filed 19 Oct 2021.